Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer

被引：1
|
作者：
Alluri, P. G. [1 ]
Larios, J. [1 ]
Malik, R. [1 ]
Rae, J. [1 ]
Chinnaiyan, A. [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
下载
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [21] FGFR1 is associated with resistance to interaction with estrogen receptor (ER) a endocrine therapy in ER+/FGFR1-amplified breast cancer
    Formisano, Luigi
    Young, Christian D.
    Bhola, Neil
    Giltnane, Jennifer M.
    Estrada, Monica V.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2015, 75
  • [22] Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
    Suzanne A. W. Fuqua
    Guowei Gu
    Yassine Rechoum
    Breast Cancer Research and Treatment, 2014, 144 : 11 - 19
  • [23] Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
    Fuqua, Suzanne A. W.
    Gu, Guowei
    Rechoum, Yassine
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (01) : 11 - 19
  • [24] Evolution of genomic alterations on endocrine therapy and mTOR inhibition in estrogen receptor (ER)-positive breast cancer
    Massarweh, S.
    Romond, E.
    Stewart, R.
    Sun, J.
    Chmielecki, J.
    Mehdi, M.
    Black, E. P.
    CANCER RESEARCH, 2016, 76
  • [25] An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Liao, Xing
    Zhu, Jian
    Wu, Gaosong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 4980 - 4990
  • [26] Identification of preclinical mechanisms driving acquired resistance to endocrine therapy in estrogen-receptor positive (ER plus ) breast cancer cells
    Ong, C.
    Daemen, A.
    Merrick, K.
    O'Brien, T.
    Friedman, L.
    Hatzivassiliou, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [27] Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk
    Massarweh, Suleiman
    Schiff, Rachel
    ENDOCRINE-RELATED CANCER, 2006, 13 : S15 - S24
  • [28] Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER plus ) breast cancer
    Toska, Eneda
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [29] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Veronica Jones
    Hongwei Holly Yin
    Yate-Ching Yuan
    Yongzhe Wang
    Sierra Min Li
    Dana Aljaber
    Angelica Sanchez
    Christine Quinones
    Dan Schmolze
    Yuan Yuan
    Joanne Mortimer
    Lisa Yee
    Laura Kruper
    Tijana Jovanovic-Talisman
    Jerneja Tomsic
    Nancy Sanchez
    Tanya Chavez
    Ruth M. O’Regan
    Qamar J. Khan
    Melissa Davis
    Kevin Kalinsky
    Jane Meisel
    Rick Kittles
    Lorna Rodriguez-Rodriguez
    Victoria Seewaldt
    Scientific Reports, 15 (1)
  • [30] Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer
    Kubo, Makoto
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
12345